China Sciences Ecorizon Tech Co., Ltd. (SHE:301175)
China · Delayed Price · Currency is CNY 6.28
+0.05 (0.80%)
Apr 14, 2026, 4:00 PM EDT
SHE:301175 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,813 | 1,613 | 1,372 | 1,586 | 1,504 |
Other Revenue | 59.38 | 49.57 | 31.63 | 10.32 | 12.07 |
| 1,873 | 1,663 | 1,404 | 1,597 | 1,516 | |
Revenue Growth (YoY) | 12.62% | 18.43% | -12.07% | 5.34% | 120.80% |
Operations & Maintenance | - | 0.01 | 0.07 | 0.03 | 0.98 |
Selling, General & Admin | 180.48 | 148.53 | 125.6 | 107.28 | 89.04 |
Provision for Bad Debts | 11.71 | 6.15 | 18.83 | -9.35 | 14.9 |
Other Operating Expenses | 1,100 | 995.49 | 835.83 | 1,115 | 1,075 |
Total Operating Expenses | 1,340 | 1,199 | 1,012 | 1,242 | 1,197 |
Operating Income | 532.63 | 463.86 | 391.81 | 354.71 | 318.55 |
Interest Expense | -89.21 | -83.41 | -83.81 | -74.3 | -77.37 |
Interest Income | 15.68 | 19.65 | 30.11 | 18.78 | 7.6 |
Net Interest Expense | -73.53 | -63.76 | -53.7 | -55.52 | -69.77 |
Currency Exchange Gain (Loss) | - | - | - | -0.34 | 0.13 |
Other Non-Operating Income (Expenses) | -2.89 | -0.34 | 2.92 | -10.18 | -7.93 |
EBT Excluding Unusual Items | 456.21 | 399.77 | 341.03 | 288.67 | 240.98 |
Gain (Loss) on Sale of Investments | - | - | 2.68 | - | - |
Gain (Loss) on Sale of Assets | 0.02 | -0.65 | 1.15 | -0.03 | -0.14 |
Asset Writedown | -0 | -4.58 | 0.1 | -0.47 | 0 |
Other Unusual Items | 6.06 | 6.77 | 8.55 | 8.45 | 3.91 |
Pretax Income | 462.28 | 401.32 | 353.51 | 296.62 | 244.76 |
Income Tax Expense | 42.17 | 39.68 | 42.84 | 46.39 | 46.44 |
Earnings From Continuing Ops. | 420.11 | 361.64 | 310.67 | 250.23 | 198.31 |
Minority Interest in Earnings | -38.34 | -40.94 | -41 | -38.09 | -25.09 |
Net Income | 381.76 | 320.69 | 269.67 | 212.14 | 173.22 |
Net Income to Common | 381.76 | 320.69 | 269.67 | 212.14 | 173.22 |
Net Income Growth | 19.04% | 18.92% | 27.12% | 22.47% | 30.21% |
Shares Outstanding (Basic) | 1,468 | 1,458 | 1,498 | 1,248 | 1,083 |
Shares Outstanding (Diluted) | 1,468 | 1,458 | 1,498 | 1,248 | 1,083 |
Shares Change (YoY) | 0.73% | -2.70% | 20.06% | 15.26% | 5.80% |
EPS (Basic) | 0.26 | 0.22 | 0.18 | 0.17 | 0.16 |
EPS (Diluted) | 0.26 | 0.22 | 0.18 | 0.17 | 0.16 |
EPS Growth | 18.18% | 22.22% | 5.88% | 6.25% | 23.08% |
Free Cash Flow | 168.73 | 166.4 | -311.36 | -185.37 | -296.3 |
Free Cash Flow Per Share | 0.12 | 0.11 | -0.21 | -0.15 | -0.27 |
Dividend Per Share | 0.160 | 0.135 | 0.100 | 0.055 | - |
Dividend Growth | 18.52% | 35.00% | 81.82% | - | - |
Profit Margin | 20.39% | 19.29% | 19.21% | 13.29% | 11.43% |
Free Cash Flow Margin | 9.01% | 10.01% | -22.18% | -11.61% | -19.55% |
EBITDA | 793.49 | 700.52 | 570.12 | 499.41 | 450.08 |
EBITDA Margin | 42.37% | 42.13% | 40.61% | 31.28% | 29.69% |
D&A For EBITDA | 260.86 | 236.66 | 178.31 | 144.71 | 131.52 |
EBIT | 532.63 | 463.86 | 391.81 | 354.71 | 318.55 |
EBIT Margin | 28.44% | 27.90% | 27.91% | 22.21% | 21.02% |
Effective Tax Rate | 9.12% | 9.89% | 12.12% | 15.64% | 18.97% |
Revenue as Reported | 1,873 | 1,663 | 1,404 | 1,597 | 1,516 |
Source: S&P Global Market Intelligence. Utility template. Financial Sources.